Advances in Surgical Pathology: Lung Cancer
Series: Advances in Surgical Pathology
This book is currently unavailable – please contact us for further information.
€132.98
(To see other currencies, click on price)
(To see other currencies, click on price)
Hardback
Overview
Products Details
Customer Reviews
MORE ABOUT THIS BOOK
Main description:
Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product.
Advances in Surgical Pathology: Lung Cancer, a volume in the Advances in Surgical Pathology series, features chapters on current and impending changes in the field of lung cancer that directly affect pathologists. This includes the 2004 updates of the WHO Classification of Tumors of the Lung; the ongoing new classification of neuroendocrine carcinomas of the lung by the International Association for the Study of Lung Cancer; the ongoing revision of the pathologic and clinical staging of lung cancer by the AJCC; molecular diagnostics in the diagnosis of lung cancer; the role of the pathologist in the new molecular targeted therapies for lung cancer; and the new use of image-guided, multimodality theranostics for the diagnosis and treatment of lung cancer. Other current topics discussed include new understanding of the premalignant and preinvasive lesions and the controversies and revisions of the diagnosis of bronchioloalveolar carcinoma.
Contents:
Section 1. Overview (include immunohistochemistry)
- Chapter 1: Introduction
- Chapter 2: Overview of Lung Cancer
- Chapter 3: Adenocarcinoma
- Chapter 4: Bronchioloalveolar Carcinomas
- Chapter 5: Changing Concepts of Bronchioloalveolar Carcinoma and Adenocarcinoma
- Chapter 6: Squamous Cell Carcinoma
- Chapter 7: Adenosquamous Carcinoma
- Chapter 8: Large Cell Carcinoma
- Chapter 9: Small Cell Carcinoma
- Chapter 10: Carcinoid Tumor
- Chapter 11: Atypical Carcinoid
- Chapter 12: Update on Classification of Neuroendocrine Carcinomas
- Chapter 13: Sarcomatoid (Sarcomatous) Carcinoma
- Chapter 14: Giant Cell Carcinoma
- Chapter 15: Pulmonary Blastoma
- Chapter 16: Salivary Gland-like Carcinomas
- Chapter 17: Metastatic Carcinoma
- Chapter 18: Correlation of Imaging with Histopathology of Lung Cancer
- Chapter 19: New Imaging Techniques for the Diagnosis and Staging of Lung Cancer
- Chapter 20: Multimodality Theranostics and Molecular Radiology in the Diagnosis and Treatment of Lung Cancer
- Chapter 21: Molecular Diagnostics of Lung Cancer
- Chapter 22: Molecular Targeted Therapy of Lung Cancer
- Chapter 23: Molecular Prognostic Markers of Lung Cancer
- Chapter 24: Problems in the Staging of Lung Cancer
- Chapter 25: New Staging System for Lung Cancer
- Chapter 26: Squamous cell carcinoma precursors
- Chapter 27: Atypical adenomatous hyperplasia
- Chapter 28: Diffuse idiopathic neuroendocrine hyperplasia
- Chapter 29: Other Precursors of Pulmonary Carcinomas
Section 2. Histopathology
Section 3. Imaging
Section 4. Molecular Pathology
Section 5. Staging
Section 6. Preneoplastic and Preinvasive Lesions
PRODUCT DETAILS
ISBN-13: 9781605475912
Publisher: Lippincott Williams & Wilkins
Publication date: November, 2010
Pages: 304
Weight: 2g
Availability: Not available (reason unspecified)
Subcategories: General Issues, Oncology, Pathology, Respiratory Medicine
Publisher: Lippincott Williams & Wilkins
Publication date: November, 2010
Pages: 304
Weight: 2g
Availability: Not available (reason unspecified)
Subcategories: General Issues, Oncology, Pathology, Respiratory Medicine
Related books
From the same series
From the same series
CUSTOMER REVIEWS
Average Rating
Doody's Note:
Includes access code for web site with additional resources.
Includes access code for web site with additional resources.
Description:
This is a comprehensive review of the current approach to lung cancer from a pathologist's perspective.
Purpose:
Pathologists are frequently required to diagnose lung cancer. How they do so, as well as the subsequent testing that minute tissue often requires, is currently subject to modification. Treatment decisions hinge on the accurate typing of carcinoma, and nonsquamous non-small-cell lung carcinomas will often require molecular testing. It also has been proposed that the International Multidisciplinary Classification of Lung Adenocarcinoma include a more accurate and standardized terminology for pulmonary adenocarcinomas. To better understand and appropriately tackle all these changes, the authors have designed "a pragmatic tool for study and for practice."
Pathologists are frequently required to diagnose lung cancer. How they do so, as well as the subsequent testing that minute tissue often requires, is currently subject to modification. Treatment decisions hinge on the accurate typing of carcinoma, and nonsquamous non-small-cell lung carcinomas will often require molecular testing. It also has been proposed that the International Multidisciplinary Classification of Lung Adenocarcinoma include a more accurate and standardized terminology for pulmonary adenocarcinomas. To better understand and appropriately tackle all these changes, the authors have designed "a pragmatic tool for study and for practice."
Audience:
The primary audience is pathologists and pathologists in training who deal with the day-to-day diagnosis of lung cancer or present to fellow clinicians at tumor boards. It also can be used for board examination study. Clearly, this is a good resource from established authorities on the subject, both as a guide for daily practice and as a means to be an informed participant at multidisciplinary conferences.
The primary audience is pathologists and pathologists in training who deal with the day-to-day diagnosis of lung cancer or present to fellow clinicians at tumor boards. It also can be used for board examination study. Clearly, this is a good resource from established authorities on the subject, both as a guide for daily practice and as a means to be an informed participant at multidisciplinary conferences.
Features:
The book deals fairly extensively with the histopathology of the various types of epithelial pulmonary malignancy, spanning carcinoid tumors, and common and unusual primary carcinomas and metastases. There are numerous images and subsections covering morphology, immunohistochemistry, and, importantly, the differential diagnosis. Current and proposed classifications and the clinical relevance of these diagnoses are elaborated. Precursor lesions are described in similar fashion. Issues with the current staging are discussed as well.
Molecular derangements, a topic currently at the forefront of pulmonary carcinoma, is dealt with via chapters on their methodology and predictive and prognostic significance. Evolving diagnostic and therapeutic modalities are also briefly touched on. As book deals with epithelial malignancies, it does not discuss benign tumors and nonepithelial malignancies.
Assessment:
This is an intelligent, current review of lung cancer for practicing pathologists and those in training. It is a handy source to use to keep abreast of all the advances in the field.
Reviewer:
Rashna Madan, M.B.B.S.
University of Kansas Medical Center
Doody's Note:
Includes access code for web site with additional resources.
Includes access code for web site with additional resources.
Description:
This is a comprehensive review of the current approach to lung cancer from a pathologist's perspective.
Purpose:
Pathologists are frequently required to diagnose lung cancer. How they do so, as well as the subsequent testing that minute tissue often requires, is currently subject to modification. Treatment decisions hinge on the accurate typing of carcinoma, and nonsquamous non-small-cell lung carcinomas will often require molecular testing. It also has been proposed that the International Multidisciplinary Classification of Lung Adenocarcinoma include a more accurate and standardized terminology for pulmonary adenocarcinomas. To better understand and appropriately tackle all these changes, the authors have designed "a pragmatic tool for study and for practice."
Pathologists are frequently required to diagnose lung cancer. How they do so, as well as the subsequent testing that minute tissue often requires, is currently subject to modification. Treatment decisions hinge on the accurate typing of carcinoma, and nonsquamous non-small-cell lung carcinomas will often require molecular testing. It also has been proposed that the International Multidisciplinary Classification of Lung Adenocarcinoma include a more accurate and standardized terminology for pulmonary adenocarcinomas. To better understand and appropriately tackle all these changes, the authors have designed "a pragmatic tool for study and for practice."
Audience:
The primary audience is pathologists and pathologists in training who deal with the day-to-day diagnosis of lung cancer or present to fellow clinicians at tumor boards. It also can be used for board examination study. Clearly, this is a good resource from established authorities on the subject, both as a guide for daily practice and as a means to be an informed participant at multidisciplinary conferences.
The primary audience is pathologists and pathologists in training who deal with the day-to-day diagnosis of lung cancer or present to fellow clinicians at tumor boards. It also can be used for board examination study. Clearly, this is a good resource from established authorities on the subject, both as a guide for daily practice and as a means to be an informed participant at multidisciplinary conferences.
Features:
The book deals fairly extensively with the histopathology of the various types of epithelial pulmonary malignancy, spanning carcinoid tumors, and common and unusual primary carcinomas and metastases. There are numerous images and subsections covering morphology, immunohistochemistry, and, importantly, the differential diagnosis. Current and proposed classifications and the clinical relevance of these diagnoses are elaborated. Precursor lesions are described in similar fashion. Issues with the current staging are discussed as well.
Molecular derangements, a topic currently at the forefront of pulmonary carcinoma, is dealt with via chapters on their methodology and predictive and prognostic significance. Evolving diagnostic and therapeutic modalities are also briefly touched on. As book deals with epithelial malignancies, it does not discuss benign tumors and nonepithelial malignancies.
Assessment:
This is an intelligent, current review of lung cancer for practicing pathologists and those in training. It is a handy source to use to keep abreast of all the advances in the field.
Reviewer:
Rashna Madan, M.B.B.S.
University of Kansas Medical Center